Ebopiprant

N/A

Report date: 2024/11/19 20:00:10
NME

Base Information

Drug NameEbopiprant
Drug Alias NameOBE-022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid FP receptor antagonists
TargetsProstanoid FP receptor
Therapy Area/IndicationsObstetric Labor, Premature
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaVietnamRussian Federation +[6] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrganonXoma CorpObseva Sa
Active IndicationsN/A
Inactive IndicationsObstetric Labor, Premature

Other Information

ATC CodeN/A
Related LinksN/A